Literature DB >> 28224485

Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).

M Arruti1, L D Piñeiro2, Y Salicio2, G Cilla2,3, M A Goenaga4, A López de Munain5,6,7,8.   

Abstract

The aim of the study was to describe the clinical and epidemiological characteristics of the central nervous system (CNS) infection by varicella zoster virus (VZV) in patients older than 65 years in a tertiary community hospital. We retrospectively analysed the results of cerebrospinal fluid (CSF) testing in patients older than 65 years between 2007 and 2014 with clinically suspected VZV infection with CNS involvement. Patients whose CSF samples were positive for VZV DNA were included, as were those with negative results who simultaneously presented herpes zoster and CSF or magnetic resonance imaging findings suggestive of CNS infection, and in whom other possible aetiologies had been ruled out. The study included 280 patients. The disease was considered to be caused by a VZV infection in 32 patients (11.4%), of which 23 cases were virologically confirmed (detection of VZV DNA in CSF). The most frequent diagnosis of the patients with VZV CNS infection was encephalitis (83.3%), followed by meningitis (13.3%) and cerebellitis (3.3%). The mean annual incidence of VZV CNS infection was 3.0 cases per 100,000 inhabitants. VZV was the most common cause of encephalitis and viral meningitis, ahead of herpes simplex virus (n = 9). At the time of discharge, 12 (40%) patients showed neurological sequelae. Five patients (20%) died during hospitalization, all with encephalitis. Patients with a fatal outcome had significantly higher median age and longer delay before initiating acyclovir. In conclusion, VZV was the first cause of encephalitis in our elderly population. Despite acyclovir treatment, there was a high rate of case fatality and sequelae at discharge.

Entities:  

Keywords:  Central nervous system infection; Encephalitis; Epidemiology; Herpes simplex virus; Varicella zoster virus

Mesh:

Substances:

Year:  2017        PMID: 28224485     DOI: 10.1007/s13365-017-0519-y

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  29 in total

1.  Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result.

Authors:  Ana A Weil; Carol A Glaser; Zahwa Amad; Bagher Forghani
Journal:  Clin Infect Dis       Date:  2002-03-21       Impact factor: 9.079

Review 2.  The global epidemiology of herpes zoster.

Authors:  Barbara P Yawn; Don Gilden
Journal:  Neurology       Date:  2013-09-03       Impact factor: 9.910

3.  Immune responses to varicella-zoster in the aged.

Authors:  B L Burke; R W Steele; O W Beard; J S Wood; T D Cain; D J Marmer
Journal:  Arch Intern Med       Date:  1982-02

4.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 5.  Neurological complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

6.  Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.

Authors:  Anna Grahn; Lars Hagberg; Staffan Nilsson; Kaj Blennow; Henrik Zetterberg; Marie Studahl
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

7.  Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection.

Authors:  Amihai Rottenstreich; Zipi Kra Oz; Ilana Oren
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-01       Impact factor: 2.803

8.  Viral infections of the central nervous system in elderly patients: a retrospective study.

Authors:  Saverio G Parisi; Monica Basso; Claudia Del Vecchio; Samantha Andreis; Elisa Franchin; Federico Dal Bello; Silvana Pagni; Maria Angela Biasolo; Riccardo Manganelli; Luisa Barzon; Giorgio Palù
Journal:  Int J Infect Dis       Date:  2016-01-25       Impact factor: 3.623

9.  Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease.

Authors:  Stephan W Aberle; Judith H Aberle; Christoph Steininger; Elisabeth Puchhammer-Stöckl
Journal:  Med Microbiol Immunol       Date:  2004-03-02       Impact factor: 4.148

Review 10.  Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Authors:  Kosuke Kawai; Berhanu G Gebremeskel; Camilo J Acosta
Journal:  BMJ Open       Date:  2014-06-10       Impact factor: 2.692

View more
  7 in total

1.  Meningitis/meningoencephalitis caused by varicella zoster virus reactivation: a retrospective single-center case series study.

Authors:  Yongxing Yan; Yanrong Yuan; Jun Wang; Yan Zhang; Huili Liu; Zuyong Zhang
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  Factors Predictive of Varicella Zoster Virus Encephalitis/Meningitis: A Single-Center, Retrospective Study.

Authors:  Yanrong Yuan; Jun Wang; Yan Zhang; Huili Liu; Yongxing Yan
Journal:  Med Sci Monit       Date:  2022-09-28

3.  Immune Responses to Varicella-Zoster Virus Glycoprotein E Formulated with Poly(Lactic-co-Glycolic Acid) Nanoparticles and Nucleic Acid Adjuvants in Mice.

Authors:  Yunfei Wang; Jialong Qi; Han Cao; Cunbao Liu
Journal:  Virol Sin       Date:  2020-08-05       Impact factor: 4.327

4.  Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy.

Authors:  Han Cao; Yunfei Wang; Ning Luan; Kangyang Lin; Cunbao Liu
Journal:  Vaccines (Basel)       Date:  2021-12-07

5.  Metagenomic next-generation sequencing of cell-free and whole-cell DNA in diagnosing central nervous system infections.

Authors:  Lili Yu; Ye Zhang; Jiemin Zhou; Yu Zhang; Xuejiao Qi; Kaixuan Bai; Zheng Lou; Yi Li; Han Xia; Hui Bu
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

6.  Varicella zoster encephalitis in an immunocompromised patient presented with migraine type headache: A case report.

Authors:  Shitiz Sriwastava; Anila Kanna; Omar Basha; Jian Xu; Kalyan Yarraguntla; Edwin George
Journal:  eNeurologicalSci       Date:  2019-08-22

7.  Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice.

Authors:  Han Cao; Yunfei Wang; Ning Luan; Cunbao Liu
Journal:  Vaccines (Basel)       Date:  2021-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.